This is what I can't understand. RGS trials are progressing well.
A significant rerate will occur in 2017 once some positive mainstream publicity occurs. Hell they can remain asleep for all I care as I continue to buy
RGS Price at posting:
14.5¢ Sentiment: Buy Disclosure: Held